KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial (420194)

ARTG ID

420194

ARTG Name

KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial

Sponsor

Eli Lilly Australia Pty Ltd

ARTG Date

May 21, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ELI LILLY AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/fa44688f3754998b07f43400de32c88e.pdf

https://medical-cdn.nocode.com/drug_tga/dde2596be8e0c9bbbef01b7818c3cf4c.pdf

Ingredient Name

donanemab

KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial (420194) - TGA 批准文号 | MedPath